727
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis

, , , &
Pages 372-378 | Received 26 Jul 2019, Accepted 01 Dec 2019, Published online: 07 Jan 2020

References

  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–386.
  • Siegel RL, Miller KD. Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
  • Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev. 2016;25:16–27. doi:10.1158/1055-9965.EPI-15-0578.
  • Navin NE. Cancer genomics: one cell at a time. Genome Biol. 2014;15:452. doi:10.1186/s13059-014-0452-9.
  • Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol. 2013;31:1806–1814. doi:10.1200/JCO.2012.46.8934.
  • Gordon BL, Finnerty BM, Aronova A, Fahey TJ 3rd. Genomic medicine for cancer diagnosis. J Surg Oncol. 2015;111:24–30. doi:10.1002/jso.23778.
  • Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 2005;78:1043–1051. doi:10.1189/jlb.0705358.
  • Oft M. IL-10: master switch from tumor-promoting inflammation to antitumor immunity. Cancer Immunol Res. 2014;2:194–199. doi:10.1158/2326-6066.CIR-13-0214.
  • Abdel Rahman HA, Khorshied MM, Reda Khorshid OM, Mourad HM. Association of interleukin-2-330T/G and interleukin-10-1082A/G genetic polymorphisms with B-cell non-hodgkin lymphoma in a cohort of Egyptians. Turk J Haematol. 2018;35:99–108. doi:10.4274/tjh.
  • Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, Ansaripour B, Moradi B, Nikbin B, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet. 2005;32:167–171. doi:10.1111/eji.2005.32.issue-3.
  • Banu C, Moise A, Arion CV, Coriu D, Tănase A, Constantinescu I. Cytokine gene polymorphisms support diagnostic monitoring of Romanian multiple myeloma patients. J Med Life. 2011;4:264–268.
  • Breen EC, Boscardin WJ, Detels R, Jacobson LP, Smith MW, O’Brien SJ, Chmiel JS, Rinaldo CR, Lai S, Martínez-Maza O, et al. Non-Hodgkin’s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter −592 C/C genotype. Clin Immunol. 2003;109:119–129. doi:10.1016/S1521-6616(03)00214-6.
  • Cunningham LM, Chapman C, Dunstan R, Bell MC, Joske DJ. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin’s lymphoma. Leuk Lymphoma. 2003;44:251–255. doi:10.1080/1042819021000035590.
  • Deng Q, Zheng T, Lan Q, Lan Y, Holford T, Chen Y, Dai M, Leaderer B, Boyle P, Chanock SJ, et al. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma. Eur J Cancer Prev. 2013;22:77–82. doi:10.1097/CEJ.0b013e328354d2c1.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269. doi:10.7326/0003-4819-151-4-200908180-00135.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605. doi:10.1007/s10654-010-9491-z.
  • Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8. doi:10.1111/j.1365-2370.1997.tb00001.x.
  • de Oliveira JG, Rossi AF, Nizato DM, Cadamuro AC, Jorge YC, Valsechi MC, Venâncio LPR, Rahal P, Pavarino ÉC, Goloni-Bertollo EM, et al. Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer. Tumour Biol. 2015;36:9159–9170. doi:10.1007/s13277-015-3593-x.
  • Nishi A, Milner DA Jr, Giovannucci EL, Nishihara R, Tan AS, Kawachi I, Ogino S. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn. 2016;16:11–23.
  • Chen R, Zheng Y, Zhuo L, Wang S. The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis. Oncotarget. 2017;8:40204–40213.
  • Wang BS, Liu Z, Xu WX, Sun SL. CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression. Tumour Biol. 2013;34:2357–2366. doi:10.1007/s13277-013-0783-2.
  • Jia J, Ren J, Yan D, Xiao L, Sun R. Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e283. doi:10.1097/MD.0000000000000283.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.